Los Angeles, CA, United States of America

Hongxiang Hui



Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Hongxiang Hui in Cancer Diagnosis and Diabetes Treatment

Introduction

Hongxiang Hui is a notable inventor based in Los Angeles, CA. He has made significant contributions to the fields of cancer diagnosis and diabetes treatment through his innovative patents. With a total of 2 patents, his work focuses on utilizing fructose-based compounds and glucose-dependent insulin-secreting cells.

Latest Patents

One of his latest patents involves the use of fructose-based compounds for the diagnosis of cancer. This invention relates to compositions and methods that utilize fructose and other monosaccharides for cancer diagnosis. Research has shown that cancer cells exhibit a higher level of fructose utilization compared to glucose. The invention leverages these characteristics, providing fructose or fructose-based compositions for cancer diagnosis using imaging techniques such as positron emission tomography.

Another significant patent by Hui discloses glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding glucagon-like peptide-1 (GLP-1). This cell line comprises insulin-secreting cells that have been modified to secrete insulin in a glucose-dependent manner. The minigene construct associated with this invention can be used to treat diabetes and investigate pancreatic cell function. It may also be implemented in devices that deliver insulin in response to glucose levels in body fluids.

Career Highlights

Hui's career is marked by his innovative research and development in medical technology. His work at Cedars-Sinai Medical Center has positioned him as a key figure in advancing treatments for diabetes and cancer diagnosis. His contributions have the potential to significantly impact patient care and treatment outcomes.

Collaborations

Hui has collaborated with notable colleagues, including Riccardo Perfetti and Anthony P. Heaney. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.

Conclusion

Hongxiang Hui's contributions to the fields of cancer diagnosis and diabetes treatment through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to improve patient outcomes and transform treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…